Metyrapone

ATC V04CD01 · 4 markets · 8 records

Metyrapone 4 markets · 8 records Forms

GB 3 records · 1 strengths

250 mgcapsuleMetopirone+1__no_trade__ also in US·AU

US 2 records · 1 strengths

250 mgcapsuleMetopirone also in GB·AU

AU 2 records · 2 strengths

250 mgcapsuleMETOPIRONE 250 metyrapone 250mg capsule bottle also in GB·US unknown

Records without a stated strength · 1 Metopirone

HK 1 records · 1 strengths

Records without a stated strength · 1 Metopirone

Side-by-side table

Strength / form / release	US	GB	AU	HK
250 mg capsule	Metopirone	No trade name Metopirone	METOPIRONE 250 metyrapone 250mg capsule bottle	not recorded
not disclosed unknown	not recorded	not recorded	Metopirone	Metopirone

Scroll horizontally for more markets →

Each country column shows the locally registered trade names — not translations.

“not disclosed” means the source does not publish the strength — it does not mean the product has none.

Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.

Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.

Back to the list

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.